Report Finds High Costs For Pay-For-Delay Drugs

Report Finds High Costs For Pay-For-Delay Drugs

Reverse payment patent settlements have left U.S. consumers paying on average 10 times more for brand-name versions of key drugs used to treat everything from breast cancer to high cholesterol while waiting for generics to enter the market, according ...read more

  • Tags: